Spiralling cancer costs must be dealt with soon, says professor

By Lucy Quinton Cancer drugs should only be given to people who would benefit in a bid to curb the spiralling costs of cancer drugs, according to Professor Karol Sikora, medical director at CancerPartnersUK. Speaking at the AMII conference, Prof Sikora said the rising cost of cancer treatment was a worldwide problem, as well as an emotional and political issue. He said a recent MORI poll found the healthcare system to be at the top of people's agenda when considering who to vote for at the next election. A total of 78% who responded said cancer was the single most important thing in t...